Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

381

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

May 17, 2022

Study Completion Date

May 17, 2022

Conditions
Psoriatic Arthritis
Interventions
DRUG

AIN457 6 mg/kg i.v.

AIN457 6 mg/kg delivered by i.v. infusion

DRUG

Placebo

Matching placebo to AIN457 i.v. infusion

DRUG

AIN457 3 mg/kg

AIN457 3 mg/kg delivered by i.v. infusion

Trial Locations (80)

1008

Novartis Investigative Site, Manila

1102

Novartis Investigative Site, Quezon City

1413

Novartis Investigative Site, Sofia

1431

Novartis Investigative Site, Sofia

4000

Novartis Investigative Site, Plovdiv

4002

Novartis Investigative Site, Plovdiv

4114

Novartis Investigative Site, Dasmariñas

4217

Novartis Investigative Site, Lipa City

7500

Novartis Investigative Site, Panorama

7600

Novartis Investigative Site, Stellenbosch

8000

Novartis Investigative Site, Burgas

10400

Novartis Investigative Site, Bangkok

10700

Novartis Investigative Site, Bangkoknoi

12462

Novartis Investigative Site, Athens

14642

Novartis Investigative Site, Rochester

16059

Novartis Investigative Site, Bursa

16635

Novartis Investigative Site, Duncansville

23608

Novartis Investigative Site, Newport News

27408

Novartis Investigative Site, Greensboro

30060

Novartis Investigative Site, Marietta

32789

Novartis Investigative Site, Winter Park

33032

Novartis Investigative Site, Miami

33324

Novartis Investigative Site, Plantation

33624

Novartis Investigative Site, Tampa

33765

Novartis Investigative Site, Clearwater

34761

Novartis Investigative Site, Ocoee

35205

Novartis Investigative Site, Birmingham

38305

Novartis Investigative Site, Jackson

40002

Novartis Investigative Site, Khon Kaen

42101

Novartis Investigative Site, Bowling Green

44130

Novartis Investigative Site, Middleburg Heights

46256

Novartis Investigative Site, Indianapolis

54622

Novartis Investigative Site, Thessaloniki

63117

Novartis Investigative Site, St Louis

68100

Novartis Investigative Site, Selangor Darul Ehsan

68516

Novartis Investigative Site, Lincoln

70300

Novartis Investigative Site, Seremban

73103

Novartis Investigative Site, Oklahoma City

74136

Novartis Investigative Site, Tulsa

75150

Novartis Investigative Site, Mesquite

78731

Novartis Investigative Site, Austin

80230

Novartis Investigative Site, Denver

90110

Novartis Investigative Site, Songkhla

90404

Novartis Investigative Site, Santa Monica

91307

Novartis Investigative Site, West Hills

91405

Novartis Investigative Site, Van Nuys

91786

Novartis Investigative Site, Upland

91942

Novartis Investigative Site, La Mesa

92708

Novartis Investigative Site, Fountain Valley

92835

Novartis Investigative Site, Fullerton

93586

Novartis Investigative Site, Kuching

110029

Novartis Investigative Site, New Delhi

110221

Novartis Investigative Site, Bogotá

111121

Novartis Investigative Site, Cundinamarca

150003

Novartis Investigative Site, Yaroslavl

190068

Novartis Investigative Site, Saint Petersburg

197022

Novartis Investigative Site, Saint Petersburg

344022

Novartis Investigative Site, Rostov-on-Don

395009

Novartis Investigative Site, Surat

603018

Novartis Investigative Site, Nizhny Novgorod

620109

Novartis Investigative Site, Yekaterinburg

650029

Novartis Investigative Site, Kemerovo

08043

Novartis Investigative Site, Voorhees Township

40150 150

Novartis Investigative Site, Salvador

04266 010

Novartis Investigative Site, São Paulo

080002

Novartis Investigative Site, Barranquilla

0001

Novartis Investigative Site, Bucaramanga

128 50

Novartis Investigative Site, Prague

140 59

Novartis Investigative Site, Prague

150 06

Novartis Investigative Site, Prague

686 01

Novartis Investigative Site, Uherské Hradiště

01001

Novartis Investigative Site, Guatemala City

01010

Novartis Investigative Site, Guatemala City

560 079

Novartis Investigative Site, Bangalore

422 101

Novartis Investigative Site, Nashik

30-510

Novartis Investigative Site, Krakow

52-200

Novartis Investigative Site, Karwiany

30 002

Novartis Investigative Site, Krakow

96-500

Novartis Investigative Site, Sochaczew

02-962

Novartis Investigative Site, Warsaw

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY